These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 9422084

  • 1. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilgers J.
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [Abstract] [Full Text] [Related]

  • 2. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
    Petrakou E, Murray A, Price MR.
    Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
    [Abstract] [Full Text] [Related]

  • 3. Epitope characterization of MUC1 antibodies.
    Imai S, Haga S, Kiyozuka Y.
    Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
    [Abstract] [Full Text] [Related]

  • 4. Epitope characterization of MUC1 antibodies.
    Blockzjil A, Nilsson K, Nilsson O.
    Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
    [Abstract] [Full Text] [Related]

  • 5. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence.
    Schol DJ, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Murakami F, Kenemans P, Hilgers J.
    Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087
    [Abstract] [Full Text] [Related]

  • 6. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J, Allard WJ, Davis G, Yeung KK.
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
    Stigbrand T, Andrés C, Bellanger L, Bishr Omary M, Bodenmüller H, Bonfrer H, Brundell J, Einarsson R, Erlandsson A, Johansson A, Leca JF, Levi M, Meier T, Nap M, Nustad K, Seguin P, Sjödin A, Sundström B, van Dalen A, Wiebelhaus E, Wiklund B, Arlestig L, Hilgers J.
    Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the carbohydrate specificity of ISOBM TD-4 Workshop anti-MUC1 antibodies.
    Lloyd KO, Kudryashov V.
    Tumour Biol; 1998; 19 Suppl 1():118-21. PubMed ID: 9422096
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
    Reis CA, Hassan H, Bennett EP, Clausen H.
    Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
    [Abstract] [Full Text] [Related]

  • 13. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI, Missailidis S, Denton G, Murray A, Brady K, Matteis CI, Searle MS, Tendler SJ, Price MR.
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
    Petrakou E, Murray A, Rosamund C, Graves L, Price MR.
    Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
    [Abstract] [Full Text] [Related]

  • 15. Determination of carbohydrate specificity of monoclonal antibodies against MUC1.
    Galanina OE, Simeoni LA, Ter-Grigoryan AG, Belyanchikov IM, Bovin NV.
    Tumour Biol; 1998; 19 Suppl 1():79-87. PubMed ID: 9422092
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K, Schol DJ, Snijdewint FG, von Mensdorff-Pouilly S, Poort-Keesom RJ, Karuntu-Wanamarta YA, Verstraeten RA, Miyazaki K, Kenemans P, Hilgers J.
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [Abstract] [Full Text] [Related]

  • 17. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P, Kandilogiannaki M, Petrarca C, von Mensdorff-Pouilly S, Hilgers JH, Krambovitis E, Arends JW, Hoogenboom HR.
    Cancer Res; 1998 Oct 01; 58(19):4324-32. PubMed ID: 9766660
    [Abstract] [Full Text] [Related]

  • 18. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
    Spencer DI, Price MR, Tendler SJ, De Matteis CI, Stadie T, Hanisch FG.
    Cancer Lett; 1996 Feb 27; 100(1-2):11-5. PubMed ID: 8620429
    [Abstract] [Full Text] [Related]

  • 19. Epitope mapping of PR81 anti-MUC1 monoclonal antibody following PEPSCAN and phage display techniques.
    Mohammadi M, Rasaee MJ, Rajabibazl M, Paknejad M, Zare M, Mohammadzadeh S.
    Hybridoma (Larchmt); 2007 Aug 27; 26(4):223-30. PubMed ID: 17725384
    [Abstract] [Full Text] [Related]

  • 20. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
    Medina M, Vélez D, Asenjo JA, Egea G, Real FX, Gil J, Subiza JL.
    Cancer Res; 1999 Mar 01; 59(5):1061-70. PubMed ID: 10070964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.